is tirzepatide hard on liver Why are GLP-1 agonists being used to treat patients with nonalcoholic fatty disease? Tirzepatide, a dual GIP/GLP-1 receptor

Similarly, other studies have reported increased expression of matrix metalloproteinases (MMPs) following exposure to heavy metals

They hypothesized that the numbers of GH peaks is the last thing lost when there is a GH secretory abnormality (16)

[DOI] [PubMed] [Google Scholar] 54.Holmay M.J., Terpstra M., Coles L.D., Mishra U., Ahlskog M., Oz G., Cloyd J.C., Tuite P.J

vitamin D intake ~20% of recommendations Lean mass risk: protein + calcium insufficiency may contribute, alongside other drivers B-vitamins: thiamine and cobalamin deficits appear to increase over time Clinical takeaway (my approach): GLP-1s dont cause malnutrition in everyone but they can unmask risk in the wrong context (older adults, low-protein diets, restrictive eating patterns, prolonged nausea/vomiting, rapid weight loss, post-bariatric patients)